BioGenex designs, develops, and commercializes advanced fully-automated Molecular Diagnostic Systems for cancer diagnosis, prognosis, therapy selection, personalized medicine, and life science research. The products include fully automated instruments, Nucleic Acid probes, Antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. The company follows a customer focused approach, with premier after-sales support and excellent technical service, provides the best-in-class customer care. Their spirit of innovation drives them to deliver cutting edge technology, years ahead of competition, and the finest reagents and instruments for life Science research and diagnostics.
Website: www.biogenex.com